Naltrexone on its own is not a typical cause of constipation, and its mechanism of action actually points in the opposite direction. As an opioid receptor blocker, naltrexone reverses the very process that makes opioid drugs slow the gut. The constipation reports that surface in prescribing information and patient forums almost always trace back to combination products, particularly the naltrexone-plus-bupropion weight-loss pill, where bupropion brings its own set of gastrointestinal effects. Sorting out which drug is doing what matters if you are trying to figure out why your gut changed after starting a naltrexone-containing medication.
How Opioids Slow the Gut in the First Place
Your gastrointestinal tract is lined with the same types of opioid receptors found in the brain. When an opioid drug activates these receptors, two things happen that conspire to produce constipation. First, the coordinated muscle contractions that push food along the intestine weaken because opioid receptor activation reduces the release of acetylcholine, the chemical signal that drives those contractions. Second, the cells lining the colon stop secreting as much fluid into the intestinal space, which dries out stool and makes it harder to pass.1PubMed Central. Insights into the Role of Opioid Receptors in the GI Tract: Experimental Evidence and Therapeutic Relevance More than half of people who use opioid medications regularly develop constipation as a result.2Journal of Gastrointestinal Motility. Colon motility in opiate addiction and naloxone-precipitated withdrawal
The mu-opioid receptor in particular is the main player. It is densely expressed on the neurons embedded in the gut wall that coordinate digestion, and it is the primary mediator of opioid-induced bowel dysfunction.3PubMed Central. Distribution and trafficking of the μ-opioid receptor in enteric neurons of the guinea pig This is the same receptor that naltrexone blocks. So if opioid activation at that receptor causes constipation, blocking it should do the opposite.
Why Naltrexone Alone Is Unlikely to Constipate You
Naltrexone is a pure opioid antagonist. It sits on opioid receptors without activating them and prevents other molecules from doing so. In the gut, this means naltrexone opposes the mechanism that slows motility and dries out stool. Animal studies confirm that naltrexone and related antagonists can reverse the inhibitory effects of the opioid system on gastrointestinal transit.4PubMed. The effect of opioid agonists and antagonists on gastrointestinal motility in mice selected for high and low swim stress-induced analgesia In people who are physically dependent on opioids, administering an antagonist like naloxone (naltrexone’s shorter-acting cousin) produces a dramatic spike in intestinal motility, resulting in abdominal cramps and diarrhea in roughly 70 to 85 percent of cases.2Journal of Gastrointestinal Motility. Colon motility in opiate addiction and naloxone-precipitated withdrawal
If anything, the pharmacology predicts the opposite of constipation. And that is exactly what the medical world has leveraged. Methylnaltrexone, a modified version of naltrexone that cannot cross into the brain, is an approved treatment for opioid-induced constipation. It speeds up intestinal transit in people whose guts have been slowed by opioid painkillers, without interfering with pain relief or triggering withdrawal symptoms.5PubMed Central. Methylnaltrexone in the treatment of opioid-induced constipation In a clinical trial, about half of patients given methylnaltrexone had a bowel movement within four hours of the first dose, compared to 15 percent on placebo.6New England Journal of Medicine. Methylnaltrexone for Opioid-Induced Constipation in Advanced Illness So the naltrexone family of molecules is literally used to treat constipation, not cause it.
Where the Constipation Reports Actually Come From
The most common reason people associate naltrexone with constipation is the combination pill naltrexone/bupropion, marketed for weight loss. Constipation is listed among the common side effects of this combination, alongside nausea, vomiting, dizziness, and dry mouth.7PubMed Central. Naltrexone/bupropion: an investigational combination for weight loss and maintenance A large phase-three trial confirmed that constipation was more frequent in the naltrexone/bupropion groups than in the placebo group.8The Lancet. Effect of combination therapy of sustained-release naltrexone and sustained-release bupropion on human body weight (COR-I): a randomised, placebo-controlled phase 3 trial
But when you see “naltrexone/bupropion causes constipation,” bupropion deserves most of the suspicion. Bupropion is a norepinephrine-dopamine reuptake inhibitor that, on its own, is well known to cause constipation. It affects the neurotransmitter balance in the gut in ways that can slow things down. The prescribing information for bupropion alone (whether for depression or smoking cessation) lists constipation as one of its most frequently reported side effects. In the combination pill, naltrexone is pharmacologically doing the opposite of what would cause constipation. The simplest explanation is that bupropion’s constipating effect outweighs naltrexone’s pro-motility effect in some people.
This distinction matters for practical decision-making. If you started a naltrexone/bupropion combination and developed constipation, the combination is the likely culprit, but switching to naltrexone alone (for a different indication) would probably not carry the same risk. Conversely, if you are taking naltrexone alone for alcohol use disorder or opioid dependence and develop constipation, the medication is an unlikely explanation and other causes should be explored first.
What About Low-Dose Naltrexone?
Low-dose naltrexone (typically 1 to 5 mg, compared to the standard 50 mg dose) has gained a following for conditions ranging from chronic pain to autoimmune disease. A survey of patients taking low-dose naltrexone found that about 61 percent reported some kind of side effect. Of those who had side effects, roughly a third experienced gastrointestinal complaints, though the study grouped these together rather than breaking them down into constipation versus diarrhea versus nausea.9PubMed. Low dose naltrexone: side effects and efficacy in gastrointestinal disorders About a quarter of those who experienced side effects described them as short-lived.
The theory behind low-dose naltrexone is that at very small doses, the brief blockade of opioid receptors triggers a rebound increase in the body’s own endorphin production, which then modulates inflammation and immune function. At these doses, the drug’s interaction with gut opioid receptors is quite different from a full 50 mg dose. Low-dose naltrexone has even been tested in irritable bowel syndrome, where a small pilot study found that about three-quarters of patients reported improved symptoms, with no significant adverse reactions.10PubMed. Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study That study was small, so the results deserve caution, but it adds to the picture that naltrexone at low doses is not a drug that characteristically worsens gut function.
Still, if you look at enough patient reports, you will find individuals who say low-dose naltrexone made them constipated. Individual variation in gut function, diet changes, or the compounding agents used in custom-prepared capsules could all play a role. These reports exist but are anecdotal and run counter to what the pharmacology would predict.
Naltrexone in People Coming Off Opioids
One scenario where naltrexone’s gut effects are dramatic is during or shortly after opioid withdrawal. When someone who has been using opioids regularly starts naltrexone, it abruptly strips opioid molecules off receptors throughout the body, including in the gut. The result is a sudden surge in intestinal motility. Clinically, this shows up as cramping and diarrhea, not constipation. Studies of naloxone-precipitated withdrawal in methadone users found significant increases in activity of the rectum and sigmoid colon, paired with withdrawal symptoms like cramping and loose stools.2Journal of Gastrointestinal Motility. Colon motility in opiate addiction and naloxone-precipitated withdrawal
This is worth knowing because it further underscores that naltrexone’s action on the gut is pro-motility, not anti-motility. In the days and weeks after withdrawal resolves, some people do experience rebound changes in bowel habits as the gut readjusts to functioning without opioids. Constipation during this adjustment period is sometimes attributed to naltrexone when it may actually reflect the gut recalibrating after a long period of opioid-induced slowing. The intestine has to re-learn its normal rhythm, and irregular bowel habits of any kind can occur temporarily.
The Peripheral Antagonist Family and Treating Constipation
Methylnaltrexone is a direct chemical derivative of naltrexone. By adding a methyl group, chemists made the molecule too bulky and water-soluble to cross the blood-brain barrier. This means it blocks opioid receptors only in the gut and other peripheral tissues while leaving the brain’s opioid receptors alone.11PubMed. Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects Patients taking morphine or other painkillers get relief from constipation without losing pain control and without experiencing withdrawal.
Methylnaltrexone is part of a class called peripherally acting mu-opioid receptor antagonists, or PAMORAs. Other members include naloxegol and naldemedine. Current treatment guidelines recommend trying standard laxatives first for opioid-induced constipation, starting with osmotic options like polyethylene glycol rather than lactulose, which can cause bloating. When laxatives are not enough, PAMORAs are the recommended second-line therapy.12Journal of Neurogastroenterology and Motility. Opioid-induced Constipation: Old and New Concepts in Diagnosis and Treatment Beyond simply unblocking the receptor, there is evidence these agents may also help repair the intestinal lining’s barrier function, which opioids can disrupt.13PubMed Central. Opioids and the Gastrointestinal Tract: The Role of Peripherally Active µ-Opioid Receptor Antagonists in Modulating Intestinal Permeability
The existence of this entire drug class, built from naltrexone’s chemical backbone and designed to treat constipation, is the strongest argument that naltrexone itself is not a constipation-causing medication.
What to Do If You Think Naltrexone Is Causing Constipation
If you are taking naltrexone (at any dose) and experiencing constipation, a few practical considerations are worth thinking through before blaming the drug.
- Check the full medication list: If you are on the naltrexone/bupropion combination, bupropion is the more likely contributor. Other medications, including certain antidepressants, antihistamines, calcium supplements, and iron supplements, are common constipation culprits that can coincide with starting naltrexone.
- Consider dietary shifts: People who begin naltrexone for alcohol use disorder sometimes dramatically change their eating and drinking habits at the same time. Cutting alcohol often means eating differently, and reduced fluid intake or a shift away from foods that previously kept things moving can affect the bowel independently.
- Look at the timing: If constipation appeared in the first week or two and then resolved, the body may have been adjusting to the medication. Transient GI changes at the start of many drugs are common and do not necessarily indicate a lasting side effect.
- Try standard first-line approaches: Adequate water intake, soluble fiber like psyllium (though guidelines suggest keeping fiber under 20 grams daily if motility is already compromised), and physical activity are standard recommendations.12Journal of Neurogastroenterology and Motility. Opioid-induced Constipation: Old and New Concepts in Diagnosis and Treatment An osmotic laxative like polyethylene glycol is a reasonable next step if those basics are not enough.
Talking to your prescriber is always reasonable if constipation persists, but going in with the understanding that naltrexone alone is a pharmacologically unlikely cause may help the conversation focus on more productive explanations.
Adverse Event Reports and What They Can and Cannot Tell You
Large pharmacovigilance databases collect reports of side effects from patients and healthcare providers, and naltrexone has accumulated a substantial file. An analysis of the FDA’s adverse event reporting system found over 28,000 reports associated with naltrexone, spanning 27 organ systems. The signals that stood out using statistical methods were primarily neurological and psychiatric, including agitation, sleep disturbances, depressed mood, and tremor.14Taylor & Francis Online / PubMed Central. Mining and disproportionality analysis of adverse events signals for naltrexone based on real-world data from the FAERS database
These databases have a limitation that matters here. They capture any side effect that a patient or doctor reports while the patient is taking the drug, regardless of whether the drug actually caused it. If someone starts naltrexone and happens to become constipated because they also started a new diet or another medication, that constipation can still end up in the database linked to naltrexone. The reporting system records co-occurrence, not causation. For a drug prescribed to tens of thousands of people, some proportion will develop constipation from other causes during treatment, and those events enter the record.
This is one reason why the clinical trial data is more informative than the raw adverse-event database. In controlled trials of naltrexone alone (for alcohol dependence, for instance), constipation does not emerge as a distinguishing side effect compared to placebo. It is in the combination-product trials where it shows up, and those trials include bupropion.
When Naltrexone Might Indirectly Affect Bowel Habits
There are a few indirect routes by which starting naltrexone could change your gut function even though the drug itself is not pharmacologically constipating. The body maintains a baseline level of endogenous opioid activity. Your own endorphins are constantly interacting with opioid receptors throughout the gut, contributing to the normal regulation of motility and secretion. When naltrexone blocks those receptors, it can shift the balance. In most people, this shift is minor or goes unnoticed. In someone whose baseline endogenous opioid tone happens to be unusually high, the change might be more perceptible, though the expected direction would still be toward looser stools rather than harder ones.
Another indirect path involves the gut microbiome. Opioid receptor signaling influences intestinal permeability, and changes in permeability can alter the microbial environment inside the gut. When naltrexone modifies opioid receptor activity at the intestinal wall, it may have downstream effects on the microbial community that are harder to predict than the direct motility effect. Research in this area is still early, but it opens the door to gut-function changes that do not fit neatly into the “agonist causes constipation, antagonist causes diarrhea” framework.
Finally, for people taking naltrexone as part of recovery from alcohol or opioid use disorder, the broader life changes that accompany early recovery can have profound effects on digestion. Stress, altered sleep, new eating patterns, changes in physical activity, and sometimes the addition of other medications all converge during the same period. Attributing a bowel change to naltrexone when so many variables are shifting simultaneously can lead to a wrong conclusion about the cause.